Baxter PE Ratio 2006-2018 | BAX

Current and historical p/e ratio for Baxter (BAX) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Baxter PE ratio as of November 19, 2018 is 22.86.
Baxter PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-11-19 65.02 29.42
2018-09-30 77.09 $2.21 34.88
2018-06-30 73.84 $1.66 44.48
2018-03-31 64.87 $1.51 42.96
2017-12-31 64.31 $1.29 49.85
2017-09-30 62.28 $1.86 33.48
2017-06-30 59.93 $1.65 36.32
2017-03-31 51.20 $3.36 15.24
2016-12-31 43.66 $8.99 4.86
2016-09-30 46.74 $8.92 5.24
2016-06-30 44.28 $8.68 5.10
2016-03-31 40.10 $7.09 5.66
2015-12-31 37.14 $1.75 21.22
2015-09-30 31.88 $3.12 10.22
2015-06-30 36.58 $3.98 9.19
2015-03-31 35.56 $4.33 8.21
2014-12-31 37.75 $4.56 8.28
2014-09-30 36.71 $3.41 10.77
2014-06-30 36.72 $3.54 10.37
2014-03-31 37.11 $3.66 10.14
2013-12-31 34.83 $3.65 9.54
2013-09-30 32.65 $3.95 8.27
2013-06-30 34.19 $4.02 8.51
2013-03-31 35.60 $4.14 8.60
2012-12-31 32.46 $4.18 7.77
2012-09-30 29.15 $4.11 7.09
2012-06-30 25.51 $4.06 6.28
2012-03-31 28.50 $3.94 7.23
2011-12-31 23.45 $3.88 6.04
2011-09-30 26.43 $3.78 6.99
2011-06-30 27.95 $3.78 7.39
2011-03-31 25.04 $3.61 6.94
2010-12-31 23.44 $3.49 6.72
2010-09-30 21.95 $3.71 5.92
2010-06-30 18.58 $3.57 5.20
2010-03-31 26.41 $3.63 7.28
2009-12-31 26.50 $3.60 7.36
2009-09-30 25.61 $3.57 7.17
2009-06-30 23.68 $3.44 6.88
2009-03-31 22.78 $3.33 6.84
2008-12-31 23.71 $3.17 7.48
2008-09-30 28.90 $3.00 9.63
2008-06-30 28.06 $2.87 9.78
2008-03-31 25.29 $2.67 9.47
2007-12-31 25.29 $2.61 9.69
2007-09-30 24.43 $2.53 9.66
2007-06-30 24.38 $2.49 9.79
2007-03-31 22.73 $2.31 9.84
2006-12-31 19.95 $2.13 9.37
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $35.393B $10.561B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Stryker (SYK) United States $64.420B 24.28
Boston Scientific (BSX) United States $51.491B 26.02
Zimmer Biomet Holdings (ZBH) United States $23.875B 15.48
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
ResMed (RMD) United States $14.846B 28.31
Perrigo (PRGO) Ireland $8.596B 13.05
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.756B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.34
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00